Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Senti Biosciences (SNTI) Return on Capital Employed (2021 - 2025)

Senti Biosciences (SNTI) has 4 years of Return on Capital Employed data on record, last reported at 0.77% in Q1 2025.

  • For Q1 2025, Return on Capital Employed changed N/A year-over-year to 0.77%; the TTM value through Mar 2025 reached 0.77%, changed N/A, while the annual FY2024 figure was 0.64%, 4.0% up from the prior year.
  • Return on Capital Employed reached 0.77% in Q1 2025 per SNTI's latest filing, up from 0.86% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.03% in Q4 2021 and bottomed at 0.86% in Q4 2023.
  • Average Return on Capital Employed over 4 years is 0.45%, with a median of 0.46% recorded in 2023.
  • The widest YoY moves for Return on Capital Employed: up -29bps in 2023, down -35bps in 2023.
  • A 4-year view of Return on Capital Employed shows it stood at 0.03% in 2021, then tumbled by -549bps to 0.19% in 2022, then plummeted by -354bps to 0.86% in 2023, then grew by 11bps to 0.77% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Capital Employed were 0.77% in Q1 2025, 0.86% in Q4 2023, and 0.75% in Q3 2023.